[HTML][HTML] Evolving role of adiponectin in cancer-controversies and update

A Katira, PH Tan - Cancer biology & medicine, 2016 - ncbi.nlm.nih.gov
Adiponectin (APN), an adipokine produced by adipocytes, has been shown to have a critical
role in the pathogenesis of obesity-associated malignancies. Through its receptor …

Serum insulin, glucose, indices of insulin resistance, and risk of lung cancer

I Argirion, SJ Weinstein, S Männistö, D Albanes… - … Biomarkers & Prevention, 2017 - AACR
Background: Although insulin may increase the risk of some cancers, few studies have
examined fasting serum insulin and lung cancer risk. Methods: We examined serum insulin …

Nutrition and dietary restrictions in cancer prevention

A Mishra, G Giuliani, VD Longo - … et Biophysica Acta (BBA)-Reviews on …, 2023 - Elsevier
The composition and pattern of dietary intake have emerged as key factors influencing
aging, regeneration, and consequently, healthspan and lifespan. Cancer is one of the major …

AdipoRon and other adiponectin receptor agonists as potential candidates in cancer treatments

E Nigro, A Daniele, A Salzillo, A Ragone… - International Journal of …, 2021 - mdpi.com
The high mortality rate together with an ever-growing number of annual cases have defined
neoplastic disorders as “the real 21st-century disease”. Its dubious distinction also results …

Association between triglyceride glucose index and non-small cell lung cancer risk in Chinese population

X Yan, Y Gao, J Tong, M Tian, J Dai… - Frontiers in Oncology, 2021 - frontiersin.org
Background Numerous studies showed that insulin resistance (IR) was associated with
cancer risk. However, few studies investigated the relationship between IR and non-small …

Metabolic syndrome and risk of lung cancer: an analysis of Korean National Health Insurance Corporation Database

S Sin, CH Lee, SM Choi, KD Han… - The Journal of Clinical …, 2020 - academic.oup.com
Introduction Metabolic syndrome is known to increase the risk of several cancers. However,
the association between lung cancer and metabolic syndrome remains unclear. Thus, we …

Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer

GP Sotiropoulos, M Dalamaga, G Antonakos, I Marinou… - Lung Cancer, 2018 - Elsevier
Objectives Chemerin is an emerging adipocytokine at the intersection of inflammation,
chemotaxis, thrombosis, fibrinolysis and metabolism. Our aims were 1) to explore circulating …

Association between diabetes risk reduction diet and lung cancer risk in 98,159 participants: results from a prospective study

Y Zhang, G Zhong, M Zhu, L Chen, H Wan… - Frontiers in …, 2022 - frontiersin.org
Purpose To evaluate the association between diabetes risk reduction diet (DRRD) score
and the risk of lung cancer in a large population. Methods Data of participants in this study …

Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome

M Dalamaga, K Karmaniolas, J Chamberland… - Metabolism, 2013 - Elsevier
Objective Excess body weight has been implicated in the pathogenesis of myelodysplastic
syndrome (MDS). We thus explored the role of serum fetuin-A reflecting ectopic hepatic fat …

Body mass index and incidence of lung cancer in the HUNT study: using observational and Mendelian randomization approaches

L Jiang, YQ Sun, BM Brumpton, A Langhammer… - BMC cancer, 2022 - Springer
Background Traditional observational studies have shown an inverse association between
body mass index (BMI) and lung cancer risk. Mendelian randomization (MR) analysis using …